Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Возможности полнодозовых фиксированных комбинаций в лечении артериальной гипертонии
Возможности полнодозовых фиксированных комбинаций в лечении артериальной гипертонии
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Диагностика и лечение артериальной гипертензии. Рекомендации Российского медицинского общества по артериальной гипертонии и Всероссийского научного общества кардиологов. Системные гипертензии. 2010; 3: 5–27.
2. Mancia G, De Backer G, Dominiczak A et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC); J Hypertens 2007; 25 (6): 1105–87.
3. Mancia G, Laurent S, Agabiti-Rosei E et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press 2009; 18 (6): 308-47.
4. ADVANCE – Action in Diabetes and Vascular Disease: patient recruitment and characteristics of the study population at baseline. Diabet Med 2005; 22: 882–8.
5. Myers MG, Asmar R, Leenen FH et al. Fixed low-dose combination therapy in hypertension – a dose response study of perindopril and indapamide. J Hypertens 2000; 18: 317–25.
6. Daniel Pella. StratiFication of cArdiovascuLar risk and evidenCe based medicine hypertensiOn treatment FORTE. Suppl. J Hypertens Abstract ESH 2010.
7. Маньковский Б.Н., Иванов Д.Д. Влияние антигипертензивной терапии на функцию почек у больных сахарным диабетом 2-го типа: результаты проспективного исследования «СКИФ-2». Лiки Украiни 2010; 8 (144).
8. Dahlöf B, Gosse P, Gueret P et al. Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study. J Hypertens 2005; 23: 2063–70.
9. Mogensen CE, Viberti G, Halimi S et al. Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIER. Hypertension 2003; 41: 1063–71.
10. Kang S, Wu YF, An N et al. A systematic review and meta-analysis of the efficacy and safety of a fixed, low-dose perindopril-indapamide combination as first-line treatment of hypertension. Clin Ther 2004; 26: 257–70.
11. PRETERAX_ 2mg/0.625mg tablet. European summary of product characteristics. Servier International, Neuilly sur Seine, France. 2003; 11.
12. Beckett NS, Peters R, Fletcher AE et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358: 1887–98.
13. BI PRETERAX_ 4mg/1.5mg tablet. European summary of product characteristics. Servier International, Neuilly sur Seine, France. 2002; 11.
14. Gosse P. Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection. Expert Rev Cardiovasc Ther 2006; 4: 319–33.
2. Mancia G, De Backer G, Dominiczak A et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC); J Hypertens 2007; 25 (6): 1105–87.
3. Mancia G, Laurent S, Agabiti-Rosei E et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press 2009; 18 (6): 308-47.
4. ADVANCE – Action in Diabetes and Vascular Disease: patient recruitment and characteristics of the study population at baseline. Diabet Med 2005; 22: 882–8.
5. Myers MG, Asmar R, Leenen FH et al. Fixed low-dose combination therapy in hypertension – a dose response study of perindopril and indapamide. J Hypertens 2000; 18: 317–25.
6. Daniel Pella. StratiFication of cArdiovascuLar risk and evidenCe based medicine hypertensiOn treatment FORTE. Suppl. J Hypertens Abstract ESH 2010.
7. Маньковский Б.Н., Иванов Д.Д. Влияние антигипертензивной терапии на функцию почек у больных сахарным диабетом 2-го типа: результаты проспективного исследования «СКИФ-2». Лiки Украiни 2010; 8 (144).
8. Dahlöf B, Gosse P, Gueret P et al. Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study. J Hypertens 2005; 23: 2063–70.
9. Mogensen CE, Viberti G, Halimi S et al. Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIER. Hypertension 2003; 41: 1063–71.
10. Kang S, Wu YF, An N et al. A systematic review and meta-analysis of the efficacy and safety of a fixed, low-dose perindopril-indapamide combination as first-line treatment of hypertension. Clin Ther 2004; 26: 257–70.
11. PRETERAX_ 2mg/0.625mg tablet. European summary of product characteristics. Servier International, Neuilly sur Seine, France. 2003; 11.
12. Beckett NS, Peters R, Fletcher AE et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358: 1887–98.
13. BI PRETERAX_ 4mg/1.5mg tablet. European summary of product characteristics. Servier International, Neuilly sur Seine, France. 2002; 11.
14. Gosse P. Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection. Expert Rev Cardiovasc Ther 2006; 4: 319–33.
Авторы
Ж.Д.Кобалава, Ю.В.Котовская, Е.А.Павлова
Российский университет дружбы народов, Москва
Российский университет дружбы народов, Москва
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.